GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Martin & Co. Inc. TN

Martin & Co. Inc. TN trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,114 shares of the company’s stock after selling 2,152 shares during the quarter. Martin & Co. Inc. TN’s holdings in GE HealthCare Technologies were worth $3,840,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Mesirow Financial Investment Management Inc. raised its holdings in GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock worth $383,000 after buying an additional 1,159 shares during the period. Cathy Pareto & Associates Inc. acquired a new stake in GE HealthCare Technologies during the 4th quarter worth about $670,000. LMR Partners LLP acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth about $7,387,000. Principal Financial Group Inc. raised its holdings in GE HealthCare Technologies by 1.9% during the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after buying an additional 19,010 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth about $1,396,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 1.4 %

Shares of GE HealthCare Technologies stock opened at $92.21 on Monday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $42.13 billion, a P/E ratio of 25.33, a PEG ratio of 2.93 and a beta of 1.15. The stock has a 50 day moving average price of $84.03 and a two-hundred day moving average price of $85.54.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th were given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.15%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date was Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is currently 3.85%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on GEHC. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup upped their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday. Finally, Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.